{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:04:11Z","timestamp":1784783051746,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,22]]},"DOI":"10.7759\/cureus.113192","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:47:42Z","timestamp":1784782062000},"source":"Crossref","is-referenced-by-count":0,"title":["Short-Term Intensive Insulin Therapy as a Remission Induction Strategy in Newly Diagnosed Type 2 Diabetes Mellitus: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Tahira","family":"Nasreen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor ul huda","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Uzair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Kumawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FNU","family":"Vanshika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazanfar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26031094","article-title":"Type 2 diabetes mellitus: new pathogenetic mechanisms, treatment and the most important complications","volume":"26","author":"M\u0142ynarska E","year":"2025","unstructured":"M\u0142ynarska E, Czarnik W, Dzie\u017ca N, et al.. Type 2 diabetes mellitus: new pathogenetic mechanisms, treatment and the most important complications. Int J Mol Sci. 2025, 26:10.3390\/ijms26031094","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1031414","article-title":"Oral antihyperglycemic therapy for type 2 diabetes mellitus","volume":"172","author":"Cheng AY","year":"2005","unstructured":"Cheng AY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ. 2005, 172:213-26. 10.1503\/cmaj.1031414","journal-title":"CMAJ"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2026.0034","article-title":"Redefining \u03b2-cell function in type 2 diabetes mellitus: from comprehensive assessment to precision medicine","volume":"50","author":"Kim Y","year":"2026","unstructured":"Kim Y, Ha J, Moon JS. Redefining \u03b2-cell function in type 2 diabetes mellitus: from comprehensive assessment to precision medicine. Diabetes Metab J. 2026, 50:235-52. 10.4093\/dmj.2026.0034","journal-title":"Diabetes Metab J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/20420188251408210","article-title":"Recent progress of remission in type 2 diabetes","volume":"16","author":"Zhao Z","year":"2025","unstructured":"Zhao Z, Yue H, Zhang X, Chen F, Xu J, Shao S. Recent progress of remission in type 2 diabetes. Ther Adv Endocrinol Metab. 2025, 16:20420188251408210. 10.1177\/20420188251408210","journal-title":"Ther Adv Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.37.7.4013","article-title":"The effect of short-term intensive insulin therapy in newly-diagnosed type-2 diabetic patients","volume":"37","author":"Karacaer C","year":"2021","unstructured":"Karacaer C, Demirci T, Cengiz H, Varim C, Tamer A. The effect of short-term intensive insulin therapy in newly-diagnosed type-2 diabetic patients. Pak J Med Sci. 2021, 37:1972-8. 10.12669\/pjms.37.7.4013","journal-title":"Pak J Med Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1687601","article-title":"Type 2 diabetes remission: multidimensional pharmacological strategies and future perspectives","volume":"16","author":"Liu Y","year":"2025","unstructured":"Liu Y, Gang X, Liu X, Jiang W, Yang Y, Wang G. Type 2 diabetes remission: multidimensional pharmacological strategies and future perspectives. Front Endocrinol (Lausanne). 2025, 16:1687601. 10.3389\/fendo.2025.1687601","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.ijem_356_24","article-title":"Realisation of remission of diabetes using pharmacotherapy (DiaRem-1)","volume":"29","author":"Sudhayakumar A","year":"2025","unstructured":"Sudhayakumar A, Arjunan D, Bhansali S, Bhujade H, Bhadada SK, Malhotra S, Walia R. Realisation of remission of diabetes using pharmacotherapy (DiaRem-1). Indian J Endocrinol Metab. 2025, 29:217-23. 10.4103\/ijem.ijem_356_24","journal-title":"Indian J Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14071427","article-title":"Research progress on downstream mechanisms of glucose metabolic reprogramming and its role in the occurrence and progression of type 2 diabetes mellitus","volume":"14","author":"Wu C","year":"2026","unstructured":"Wu C, Wei M, Li A, et al.. Research progress on downstream mechanisms of glucose metabolic reprogramming and its role in the occurrence and progression of type 2 diabetes mellitus. Biomedicines. 2026, 14:1427. 10.3390\/biomedicines14071427","journal-title":"Biomedicines"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/1524839919893361","article-title":"A review of the PubMed PICO tool: using evidence-based practice in health education","volume":"21","author":"Brown D","year":"2020","unstructured":"Brown D. A review of the PubMed PICO tool: using evidence-based practice in health education. Health Promot Pract. 2020, 21:496-8. 10.1177\/1524839919893361","journal-title":"Health Promot Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080122","article-title":"Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trial","volume":"387","author":"Liu L","year":"2024","unstructured":"Liu L, Ke W, Li H, et al.. Intense simplified strategy for newly diagnosed type 2 diabetes in patients with severe hyperglycaemia: multicentre, open label, randomised trial. BMJ. 2024, 387:e080122. 10.1136\/bmj-2024-080122","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.70187","article-title":"Effects of short-term intensive insulin therapy combined with oral hypoglycemic agents for inducing remission in newly diagnosed type 2 diabetes mellitus: a randomized clinical trial","volume":"18","author":"Ke W","year":"2026","unstructured":"Ke W, Liu L, Zhang P, et al.. Effects of short-term intensive insulin therapy combined with oral hypoglycemic agents for inducing remission in newly diagnosed type 2 diabetes mellitus: a randomized clinical trial. J Diabetes. 2026, 18:e70187. 10.1111\/1753-0407.70187","journal-title":"J Diabetes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.55730\/1300-0144.5616","article-title":"The effects of early short-term insulin treatment vs. glimepiride on beta cell function in newly diagnosed type 2 diabetes with HbA1c above 9","volume":"53","author":"Stojanovic J","year":"2023","unstructured":"Stojanovic J, Andjelic-Jelic M, Vuksanovic M, Marjanovic-Petkovic M, Jojic B, Stojanovic M, Beljic-Zivkovic T. The effects of early short-term insulin treatment vs. glimepiride on beta cell function in newly diagnosed type 2 diabetes with HbA1c above 9. Turk J Med Sci. 2023, 53:552-62. 10.55730\/1300-0144.5616","journal-title":"Turk J Med Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14421","article-title":"Short-term intensive insulin as induction and maintenance therapy for the preservation of beta-cell function in early type 2 diabetes (RESET-IT Main): a 2-year randomized controlled trial","volume":"23","author":"Retnakaran R","year":"2021","unstructured":"Retnakaran R, Emery A, Ye C, et al.. Short-term intensive insulin as induction and maintenance therapy for the preservation of beta-cell function in early type 2 diabetes (RESET-IT Main): a 2-year randomized controlled trial. Diabetes Obes Metab. 2021, 23:1926-35. 10.1111\/dom.14421","journal-title":"Diabetes Obes Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40287-w","article-title":"Determinants of sustained stabilization of beta-cell function following short-term insulin therapy in type 2 diabetes","volume":"14","author":"Retnakaran R","year":"2023","unstructured":"Retnakaran R, Pu J, Emery A, et al.. Determinants of sustained stabilization of beta-cell function following short-term insulin therapy in type 2 diabetes. Nat Commun. 2023, 14:4514. 10.1038\/s41467-023-40287-w","journal-title":"Nat Commun"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia U","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, et al.. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020, 21:10.3390\/ijms21176275","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2025.0644","article-title":"Hepatic insulin resistance and steatosis in metabolic dysfunction-associated steatotic liver disease: new insights into mechanisms and clinical implications","volume":"49","author":"Truong XT","year":"2025","unstructured":"Truong XT, Lee DH. Hepatic insulin resistance and steatosis in metabolic dysfunction-associated steatotic liver disease: new insights into mechanisms and clinical implications. Diabetes Metab J. 2025, 49:964-86. 10.4093\/dmj.2025.0644","journal-title":"Diabetes Metab J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fcdhc.2026.1792614","article-title":"Nutrition-induced remission of type 2 diabetes: mechanisms, clinical evidence, and future directions-a mini review","volume":"7","author":"Pescari D","year":"2026","unstructured":"Pescari D, Mihuta S, Bena A, Pui R, Paul C, Stoian D. Nutrition-induced remission of type 2 diabetes: mechanisms, clinical evidence, and future directions-a mini review. Front Clin Diabetes Healthc. 2026, 7:1792614. 10.3389\/fcdhc.2026.1792614","journal-title":"Front Clin Diabetes Healthc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(25)00163-9","article-title":"The central role of recovery of \u03b2-cell function in the remission of prediabetes: a prospective cohort study in Canada","volume":"13","author":"Retnakaran R","year":"2025","unstructured":"Retnakaran R, Pu J, Shen J, Hanley AJ, Zinman B. The central role of recovery of \u03b2-cell function in the remission of prediabetes: a prospective cohort study in Canada. Lancet Diabetes Endocrinol. 2025, 13:829-37. 10.1016\/S2213-8587(25)00163-9","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/nu15092217","article-title":"Beta cell dysfunction in youth- and adult-onset type 2 diabetes: an extensive narrative review with a special focus on the role of nutrients","volume":"15","author":"Serbis A","year":"2023","unstructured":"Serbis A, Giapros V, Tsamis K, Balomenou F, Galli-Tsinopoulou A, Siomou E. Beta cell dysfunction in youth- and adult-onset type 2 diabetes: an extensive narrative review with a special focus on the role of nutrients. Nutrients. 2023, 15:10.3390\/nu15092217","journal-title":"Nutrients"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/501297-short-term-intensive-insulin-therapy-as-a-remission-induction-strategy-in-newly-diagnosed-type-2-diabetes-mellitus-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:47:52Z","timestamp":1784782072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/501297-short-term-intensive-insulin-therapy-as-a-remission-induction-strategy-in-newly-diagnosed-type-2-diabetes-mellitus-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.113192","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}